The Effect of Vildagliptin Relative to Sulphonylureas in Muslim Patients With Type 2 Diabetes Fasting During Ramadan: The VIRTUE Study

被引：0
|
作者：
Al Arouj, Monira
Hassoun, Ahmed A. K.
Medlej, Rita
Pathan, Faruque M.
Shaltout, Inass
Chawla, Manoj S.
Geransar, Parnia
Hristoskova, Sashka
Ditommaso, Shelley
Kadwa, Mahomed Y.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1112-P
引用
收藏
页码：A288 / A289
页数：2
相关论文
共 50 条
  • [1] The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study
    Hassoun, A.
    Al-Arouj, M.
    Medlej, R.
    Pathan, M. F.
    Shaltout, I.
    Chawla, M. S.
    Geransar, P.
    Hristoskova, S.
    DiTommaso, S.
    Kadwa, M. Y.
    [J]. DIABETOLOGIA, 2013, 56 : S240 - S241
  • [2] The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study
    Al-Arouj, M.
    Hassoun, A. A. K.
    Medlej, R.
    Pathan, M. F.
    Shaltout, I.
    Chawla, M. S.
    Hristoskova, S.
    DiTommaso, S.
    Kadwa, M. Y.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (10) : 957 - 963
  • [3] VIRTUE Study: Effects of Vildagliptin Relative to Sulphonylureas Either as Monotherapy or in Combination with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan
    Shaltout, Inass
    Pathan, Faruque
    Medlej, Rita
    Al Arouj, Monira
    Hassoun, Ahmed A. K.
    Chawla, Manoj S.
    Knap, Ditte
    Vaz, Julius A.
    [J]. DIABETES, 2014, 63 : A565 - A565
  • [4] VIRTUE study: effects of vildagliptin versus sulphonylureas as monotherapy or combined with metformin in Muslim patients with type 2 diabetes fasting during Ramadan
    Shaltout, I.
    Pathan, F.
    Medlej, R.
    Al-Arouj, M.
    Hassoun, A. A. K.
    Chawla, M. S.
    Knap, D.
    Vaz, J. A.
    [J]. DIABETOLOGIA, 2014, 57 : S359 - S359
  • [5] Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
    Khattab, Mohamed
    Mahmoud, Khalifa
    Shaltout, Inass
    [J]. DIABETES THERAPY, 2016, 7 (03) : 551 - 560
  • [6] Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
    Mohamed Khattab
    Khalifa Mahmoud
    Inass Shaltout
    [J]. Diabetes Therapy, 2016, 7 : 551 - 560
  • [7] The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study
    Hassoun, Ahmed A. K.
    Al-Arouj, Monira
    Ibrahim, Mohamed
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) : 161 - 167
  • [8] Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
    Hassoun, Ahmed A. K.
    Pathan, Md Faruque
    Medlej, Rita C.
    Alarouj, Monira
    Shaltout, Inass
    Chawla, Manoj S.
    Knap, Ditte
    Vaz, Julius A.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 225 - 231
  • [9] Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan
    Shete, Abhijit
    Shaikh, Aheson
    Nayeem, K. Javeed
    Rodrigues, Lily
    Ali, Mohamed Sheikamunadeen Sadiq
    Shah, Parag
    Khanna, Rajiv
    Majid, Sarfaraj
    Rasheed, Sabeer A.
    Shaikh, Shehla
    Rahman, Tawfiqur
    [J]. WORLD JOURNAL OF DIABETES, 2013, 4 (06): : 358 - 364
  • [10] Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan
    Devendra, D.
    Gohel, B.
    Bravis, V.
    Hui, E.
    Salih, S.
    Mehar, S.
    Hassanein, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (10) : 1446 - 1450
12345